Cell Biotech Co ., Limited. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cell Biotech Co ., Limited. with three other
companies in this sector in South Korea:
ISU Abxis Company Limited
sales of 19.05 billion Korean Won [US$17.85 million]
of which 98%
was Antibody Medicine),
Komipharm International Company Limited
(37.64 billion Korean Won [US$35.27 million]
of which 100%
was Animal Pharmaceutical), and
Choong Ang Vaccine Laboratory
(37.90 billion Korean Won [US$35.51 million]
Cell Biotech Co ., Limited. reported sales of 58.28 billion Korean Won (US$54.60 million)
December of 2016.
increase of 17.7%
versus 2015, when the company's sales were 49.50 billion Korean Won.
Sales at Cell Biotech Co ., Limited. have increased during each of the previous five years
(and since 2011, sales have increased a total of 150%).
Sales of Finished Products saw an increase
22.0% in 2016, from
41.80 billion Korean Won to 51.02 billion Korean Won.
Not all segments of Cell Biotech Co ., Limited. experienced an increase in sales in 2016:
sales of Raw Material fell 5.8% to 7.26 billion Korean Won.